Valneva SE (VALN) Other Working Capital Changes (2021 - 2026)
Valneva SE's (VALN) quarterly Other Working Capital Changes came in at -$801960.8 in Q1 2026, down 11.3% year-on-year from -$904125.5 in Q1 2025, and down 4.57% quarter-over-quarter from -$766900.1 in Q3 2025.
Valneva SE (VALN) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$801960.8 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$801960.8, down 11.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.1 million (down 5.0% YoY), and the FY2024 annual result was -$2.9 million, up 13.64% from the prior year.
- Other Working Capital Changes came in at -$801960.8 for Q1 2026 at Valneva SE, down from -$766900.1 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.9 billion in Q3 2023 to a low of -$1.9 billion in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$753718.7 (2022), against an average of -$825700.5.
- Peak annual rise in Other Working Capital Changes reached 292306.32% in 2023, while the deepest fall reached 255621.4% in 2023.
- Valneva SE's Other Working Capital Changes stood at -$894756.9 in 2022, then climbed by 17.87% to -$734867.0 in 2023, then jumped by 110.03% to $73733.1 in 2024, then slumped by 1140.1% to -$766900.1 in 2025, then fell by 4.57% to -$801960.8 in 2026.
- The last three Other Working Capital Changes figures came in at -$801960.8 (Q1 2026), -$766900.1 (Q3 2025), and -$791239.8 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -801,960.77 |
| Mar 31, 2026 | -801,960.77 |
| Sep 30, 2025 | -766,900.14 |
| Sep 30, 2025 | -766,900.14 |
| Jun 30, 2025 | -791,239.82 |
| Jun 30, 2025 | -791,239.82 |
| Mar 31, 2025 | -720,540.84 |
| Mar 31, 2025 | -720,540.84 |
| Dec 31, 2024 | 73,733.08 |
| Dec 31, 2024 | 73,733.08 |
| Sep 30, 2024 | -716,039.12 |
| Sep 30, 2024 | -716,039.12 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | -735,466.92 |
| Mar 31, 2024 | -735,466.92 |
| Dec 31, 2023 | -734,866.96 |
| Dec 31, 2023 | -734,866.96 |
| Sep 30, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.89 Bn |